| A field trial to assess a blood-stage malaria vaccine MA Thera, OK Doumbo, D Coulibaly, MB Laurens, A Ouattara, AK Kone, ... New England Journal of Medicine 365 (11), 1004-1013, 2011 | 424 | 2011 |
| Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria SD Polley, T Mwangi, CHM Kocken, AW Thomas, S Dutta, DE Lanar, ... Vaccine 23 (5), 718-728, 2004 | 273 | 2004 |
| Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research DG Heppner Jr, KE Kester, CF Ockenhouse, N Tornieporth, O Ofori, ... Vaccine 23 (17-18), 2243-2250, 2005 | 256 | 2005 |
| IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life SM Kinyanjui, DJ Conway, DE Lanar, K Marsh Malaria journal 6, 1-8, 2007 | 236 | 2007 |
| Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A MD Spring, JF Cummings, CF Ockenhouse, S Dutta, R Reidler, E Angov, ... PloS one 4 (4), e5254, 2009 | 235 | 2009 |
| Fractional third and fourth dose of RTS, S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria parasite infection and immunogenicity study JA Regules, SB Cicatelli, JW Bennett, KM Paolino, PS Twomey, JE Moon, ... The Journal of infectious diseases 214 (5), 762-771, 2016 | 210 | 2016 |
| Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity M Coccia, C Collignon, C Hervé, A Chalon, I Welsby, S Detienne, ... npj Vaccines 2 (1), 25, 2017 | 193 | 2017 |
| DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity I Chuang, M Sedegah, S Cicatelli, M Spring, M Polhemus, C Tamminga, ... PloS one 8 (2), e55571, 2013 | 157 | 2013 |
| Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites S Dutta, JD Haynes, JK Moch, A Barbosa, DE Lanar Proceedings of the National Academy of Sciences 100 (21), 12295-12300, 2003 | 154 | 2003 |
| Structural basis of antigenic escape of a malaria vaccine candidate S Dutta, SY Lee, AH Batchelor, DE Lanar Proceedings of the National Academy of Sciences 104 (30), 12488-12493, 2007 | 148 | 2007 |
| Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli S Dutta, PV Lalitha, LA Ware, A Barbosa, JK Moch, MA Vassell, BB Fileta, ... Infection and immunity 70 (6), 3101-3110, 2002 | 136 | 2002 |
| Antibodies to Plasmodium falciparum Antigens Predict a Higher Risk of Malaria But Protection From Symptoms Once Parasitemic B Greenhouse, B Ho, A Hubbard, D Njama-Meya, DL Narum, DE Lanar, ... Journal of Infectious Diseases 204 (1), 19-26, 2011 | 127 | 2011 |
| Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial MA Thera, OK Doumbo, D Coulibaly, DA Diallo, AK Kone, AB Guindo, ... PloS one 3 (1), e1465, 2008 | 124 | 2008 |
| Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2. 1, adjuvanted with AS02A, in malaria-naive adults at the … ME Polhemus, AJ Magill, JF Cummings, KE Kester, CF Ockenhouse, ... Vaccine 25 (21), 4203-4212, 2007 | 121 | 2007 |
| Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology MS Hsiang, J Hwang, S Kunene, C Drakeley, D Kandula, J Novotny, ... PLoS one 7 (1), e29550, 2012 | 114 | 2012 |
| Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane … RO Payne, KH Milne, SC Elias, NJ Edwards, AD Douglas, RE Brown, ... The Journal of infectious diseases 213 (11), 1743-1751, 2016 | 112 | 2016 |
| A malaria vaccine adjuvant based on recombinant antigen binding to liposomes WC Huang, B Deng, C Lin, KA Carter, J Geng, A Razi, X He, U Chitgupi, ... Nature nanotechnology 13 (12), 1174-1181, 2018 | 111 | 2018 |
| Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1 S Dutta, LS Dlugosz, DR Drew, X Ge, D Ababacar, YI Rovira, JK Moch, ... PLoS pathogens 9 (12), e1003840, 2013 | 100 | 2013 |
| Mapping functional humoral correlates of protection against malaria challenge following RTS, S/AS01 vaccination TJ Suscovich, JK Fallon, J Das, AR Demas, J Crain, CH Linde, A Michell, ... Science translational medicine 12 (553), eabb4757, 2020 | 97 | 2020 |
| Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component C Tamminga, M Sedegah, D Regis, I Chuang, JE Epstein, M Spring, ... PLOS one 6 (10), e25868, 2011 | 97 | 2011 |
